Magnetic Resonance Angiography Market Size 2025-2029
The magnetic resonance angiography market size is forecast to increase by USD 934.3 million, at a CAGR of 5.6% between 2024 and 2029.
The rising global incidence of cardiovascular and neurological diseases underpins the steady demand in the global magnetic resonance angiography market. This sustained clinical need for precise, non-invasive vascular assessment supports investment in advanced diagnostic imaging market technologies. Innovations such as AI in MRI are transforming the field by enhancing workflow efficiency and diagnostic accuracy. These systems offer detailed anatomical information, which is critical for the diagnosis and management of conditions like coronary artery disease and cerebral aneurysms. The preference for radiation-free procedures further solidifies the role of MRA in modern diagnostics, especially for pediatric patients and those requiring longitudinal monitoring, distinguishing it from options like the computed tomography (CT) market.The integration of artificial intelligence into MRA workflows is a defining market trend, enabling faster scan times and automated post-processing. This not only improves departmental throughput but also enhances diagnostic consistency. AI-powered tools assist in complex tasks such as vessel segmentation and stenosis measurement, augmenting the capabilities of radiologists. However, the substantial capital outlay for MRA systems presents a considerable challenge. These high costs, which include installation and maintenance, can limit access to this advanced technology, particularly in smaller healthcare facilities or regions with constrained budgets. This financial barrier affects the broader adoption of peripheral vascular diagnostic systems and other advanced imaging tools.
What will be the Size of the Magnetic Resonance Angiography Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The global magnetic resonance angiography market is shaped by the continuous integration of advanced imaging modalities. The development of non-contrast MRA for renal artery imaging reflects a move toward safer diagnostic protocols. Enhanced MRA for abdominal vasculature is becoming essential for pre-surgical planning. Real-time MRA for cardiac imaging provides dynamic functional assessments, a key area in the diagnostic imaging market.AI algorithms for MRA image segmentation are streamlining workflows by automating vessel outlining. Concurrently, AI-driven MRA artifact reduction is improving image clarity for more reliable diagnoses. The application of time-resolved MRA of peripheral vessels is improving the management of peripheral artery disease by offering detailed hemodynamic information, complementing tools in the peripheral vascular diagnostic systems market.Advanced applications such as quantitative MRA for cerebral blood flow measurement are providing critical data for neurological research. The development of MRA for carotid plaque characterization helps in assessing stroke risk beyond simple stenosis measurement. These evolving techniques underscore the market's shift toward providing more comprehensive and quantitative diagnostic information.
How is this Magnetic Resonance Angiography Industry segmented?
The magnetic resonance angiography industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Technique
- Non-contrast enhanced MRA
- Contrast enhanced MRA
- Application
- Abdomen
- Lower extremities
- Others
- End-user
- Geography
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- The Netherlands
- Asia
- Rest of World (ROW)
By Technique Insights
The non-contrast enhanced mra segment is estimated to witness significant growth during the forecast period.
Non-contrast enhanced MRA (NCE-MRA) techniques are designed to visualize blood vessels without external contrast agents, driven by a focus on patient safety. These methods are standard for patients with contraindications to gadolinium, such as those with severe kidney disease. Techniques leverage the physical properties of flowing blood to create contrast. The Rest of World (ROW) region, which presents 10.51% of the geographic opportunity, is a key area where cost-effective and safe imaging solutions like NCE-MRA are gaining traction.
Common NCE-MRA methods include time-of-flight, phase-contrast, and arterial spin labeling. While well-established for neurological applications, advancements are expanding their use to more challenging areas like renal and peripheral arteries. Innovations aim to overcome limitations such as lower signal-to-noise ratio and longer scan times. This development path is critical for making vascular imaging safer and more accessible to a broader patient population globally, particularly in emerging markets where safety and cost are paramount concerns for healthcare providers.

Request Free Sample
The Non-contrast enhanced MRA segment was valued at USD 1.7 billion in 2019 and showed a gradual increase during the forecast period.

Regional Analysis
Europe is estimated to contribute 32.3% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Request Free Sample
Europe stands as the second-largest market for magnetic resonance angiography, supported by advanced healthcare systems and a strong commitment to public health. The region's large and aging population drives consistent demand for diagnostics related to vascular conditions. A defining characteristic of the market in Europe is the stringent regulatory framework, which promotes high standards of product safety and clinical evidence. This has made Europe a leading adopter of innovative non-contrast MRA techniques, aligning with the clinical push to minimize gadolinium use.
The market in Europe is expected to contribute 32.3% of the incremental growth during the forecast period, reflecting continued investment and technological adoption. The focus on early diagnosis and preventative medicine, coupled with significant funding for academic and clinical research, ensures stable growth. Modernization of healthcare infrastructure in Eastern European countries presents further opportunities, as these nations align their diagnostic capabilities with Western European standards, expanding the reach of advanced MRA technologies across the continent.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The Global Magnetic Resonance Angiography (MRA) market is experiencing robust growth, fueled by its crucial role in modern diagnostics. Key drivers include the widespread use of MRA in the management of peripheral artery disease and its application as a non-invasive MRA for stroke evaluation. Clinicians are adopting advanced methods like contrast-enhanced MRA for abdominal aorta and non-contrast MRA for renal artery imaging. The technology's precision is vital for MRA for detecting intracranial aneurysms and detailed MRA for carotid plaque characterization. Innovations such as time-resolved MRA of peripheral vessels and functional MRA for assessing vascular reactivity are expanding diagnostic capabilities. The market also sees growth in niche areas like pediatric MRA of congenital heart disease, the integration of MRA with PET for hybrid vascular imaging, and the promising field of MRA-guided focused ultrasound therapy.Technological evolution is propelling market expansion, with a significant emphasis on image quality and efficiency. The adoption of AI algorithms for MRA image segmentation and the use of AI-driven MRA artifact reduction techniques are enhancing diagnostic accuracy. Simultaneously, hardware advancements like ultra-high-field MRA for small vessel imaging are enabling new clinical insights. Leading OEMS are innovating with MRA sequences for metal artifact reduction and focusing on MRA protocol optimization for slow flow. The development of quantitative MRA for cerebral blood flow measurement and real-time MRA for cardiac imaging marks a move toward dynamic functional assessments. Future growth will be shaped by applications in enhanced MRA for abdominal vasculature and the potential of point-of-care MRA for emergency diagnostics.

What are the key market drivers leading to the rise in the adoption of Magnetic Resonance Angiography Industry?
- The increasing prevalence of cardiovascular and neurological diseases globally is a fundamental driver for the market.
A primary driver for the global magnetic resonance angiography market is the increasing global prevalence of cardiovascular and neurological diseases. Conditions such as coronary artery disease, peripheral artery disease, and cerebral aneurysms are becoming more common, largely due to an aging global population. It is noted that one in six people worldwide will be aged 60 or over by 2030, a demographic highly susceptible to vascular pathologies. This trend is compounded by lifestyle factors that contribute to comorbidities like hypertension and diabetes. Magnetic resonance angiography (MRA) is a premier non-invasive diagnostic tool, providing detailed 3D anatomical information of blood vessels without using ionizing radiation. This sustained clinical need drives investment in MRA systems for high-quality patient care.Technological advancement is a powerful driver of growth in the global magnetic resonance angiography market. Innovation spans hardware, such as ultra-high-field MRI systems and improved gradient coil technology, to transformative software developments integrating artificial intelligence and machine learning. In some developed nations, where nearly one-fourth of the population is projected to be over 60 by 2050, the need for efficient and accurate diagnostics is paramount. AI-powered tools automate post-processing tasks like vessel segmentation, improving workflow efficiency and diagnostic consistency. Furthermore, a significant focus on advancing non-contrast MRA techniques is enhancing patient safety by eliminating gadolinium-based agents. These collective advancements make MRA a faster, safer, and more accurate diagnostic tool, expanding its clinical utility and adoption over competing modalities.
What are the market trends shaping the Magnetic Resonance Angiography Industry?
- The integration of artificial intelligence and machine learning represents the most transformative trend within the market.
The integration of artificial intelligence and machine learning is a transformative trend in the global magnetic resonance angiography market. In some rapidly aging economies, where it is expected that nearly half of the population will be aged 60 or older by 2050, the efficiency gains from AI are critical. AI is applied throughout the MRA workflow, from image acquisition with deep learning reconstruction that reduces scan times, to automated post-processing. AI algorithms can automatically segment blood vessels, quantify stenosis, and detect aneurysms, leading to faster, more standardized reporting. This automation not only enhances departmental throughput but also improves diagnostic accuracy and consistency. The trend is shifting the radiologist's role toward that of a diagnostic consultant augmented by powerful computational tools, impacting the broader diagnostic imaging market.A dominant trend within the global magnetic resonance angiography market is the clinical adoption of non-contrast enhanced techniques. Europe, which accounts for 32.29% of the geographic opportunity, is a leading region in this shift. This movement is motivated by a focus on patient safety and eliminating risks associated with gadolinium-based contrast agents, such as nephrogenic systemic fibrosis and gadolinium deposition. Techniques like Time-of-Flight and Arterial Spin Labeling are becoming more robust, overcoming traditional limitations like lower signal-to-noise ratios. As a result, non-contrast MRA is now standard for many applications, including intracranial imaging. This trend expands the patient population that can safely undergo MRA, simplifies workflows, and positions MRA as a safer alternative in the cardiovascular ultrasound imaging systems market.
What challenges does the Magnetic Resonance Angiography Industry face during its growth?
- The high cost of MRA systems and associated procedures remains a significant challenge impeding market growth.
A significant challenge facing the global magnetic resonance angiography market is the substantial cost of the technology. The initial capital investment for a new MRI system can be millions of dollars, with additional costs for shielded room construction and ongoing maintenance. This financial barrier can be insurmountable for smaller hospitals and facilities in low-resource settings, limiting patient access. In price-sensitive healthcare systems, the high per-procedure cost of MRA can lead to the use of less expensive alternatives like ultrasound. Although North America represents 30.08% of the geographic opportunity, cost-containment pressures even in this mature market can affect technology adoption rates. These high costs remain a primary constraint on market growth and create disparities in the availability of state-of-the-art vascular imaging.The effective use of magnetic resonance angiography is constrained by a global shortage of skilled professionals. Operating MRI scanners and performing complex MRA protocols requires specially trained technologists, while accurate interpretation demands experienced radiologists with subspecialty training in neuroradiology or cardiovascular imaging. The global demand for these experts often exceeds the supply. This scarcity leads to increased workloads, long patient wait times for procedures and reports, and limits the ability of facilities to offer advanced MRA services. In many developing countries, where Asia accounts for 27.12% of the growth opportunity, this workforce shortage is even more acute, severely limiting access to care. While AI tools are being developed to assist, they do not yet replace expert human oversight, making the skills gap a persistent barrier.
Exclusive Customer Landscape
The magnetic resonance angiography market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the magnetic resonance angiography market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, magnetic resonance angiography market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Alltech Medical Systems LLC - Companies in the magnetic resonance angiography market provide advanced imaging solutions designed for comprehensive vascular assessment. These offerings include high-field MRI systems, such as 1.5T and 3.0T scanners, equipped with specialized software and hardware for neurovascular, cardiovascular, and peripheral vascular imaging. Key technologies facilitate both contrast-enhanced and non-contrast-enhanced techniques to serve diverse clinical needs and patient safety requirements. The systems are engineered to support applications ranging from routine diagnostic scans in extremities and the abdomen to complex intraoperative and preclinical research imaging. Offerings also extend to components like superconducting magnets and AI-powered platforms that enhance image quality, automate post-processing, and improve workflow efficiency.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Alltech Medical Systems LLC
- ASG Superconductors Spa
- Bruker Corp.
- Esaote Spa
- FONAR Corp.
- GE Healthcare Technologies Inc.
- Hitachi Ltd.
- Hyperfine Inc.
- IMRIS Deerfield Imaging Inc.
- Koninklijke Philips NV
- Neusoft Medical Systems Co. Ltd.
- Samsung Electronics Co. Ltd.
- Shanghai United Imaging Healthcare Co. Ltd.
- Shenzhen Anke High tech Co.
- Shimadzu Corp.
- Siemens Healthineers AG
- Time Medical Holding
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Magnetic Resonance Angiography Market
In March 2024, at the European Congress of Radiology, Royal Philips announced the launch of its latest AI-enhanced MR imaging portfolio, featuring innovations designed to increase productivity and improve diagnostic confidence in MRA and other applications.In February 2024, Siemens Healthineers announced it had received U.S. Food and Drug Administration clearance for its MAGNETOM Flow, a 1.5T MRI scanner featuring a closed helium circuit and designed to expand access to MRI technology with simplified workflows and AI-powered tools.In February 2024, GE HealthCare showcased its latest advancements in AI and deep learning solutions at the European Congress of Radiology, including new capabilities for its MRI systems that improve image quality and reduce scan times for complex vascular imaging.
Research Analyst Overview
The global magnetic resonance angiography market is defined by its central role in non-invasive vascular imaging, providing critical data for cardiovascular diseases diagnostics and neurological diseases diagnostics. The dynamic between contrast enhanced MRA, which often uses gadolinium-based contrast agents, and non-contrast enhanced MRA techniques like time-of-flight MRA and phase-contrast MRA is continually evolving due to concerns over nephrogenic systemic fibrosis and gadolinium deposition concerns. This positions magnetic resonance angiography as a key alternative to methods involving ionizing radiation exposure, such as computed tomography angiography, and more invasive procedures like catheter angiography. Its clinical utility is demonstrated in applications from carotid artery imaging and cerebral aneurysm detection to evaluating renal artery stenosis imaging and abdominal aortic aneurysms, including intracranial aneurysms and peripheral artery disease imaging.Technological progression is reshaping procedural capabilities, with AI-powered image analysis and deep learning reconstruction enabling sophisticated automated vessel segmentation and stenosis quantification. Hardware evolution from low-field MRI systems to high-field MRI systems, including advanced 3T and 7T scanners, depends on innovations in gradient coil technology and radiofrequency coil technology for superior motion artifact reduction. Advanced techniques such as arterial spin labeling, quiescent-inflow suppression, fresh-blood imaging sequences, and balanced steady-state free precession are becoming more common. The development of point-of-care MRI systems expands accessibility, while the industry adapts to the presence of MR-conditional medical implants. The market is projected to expand by approximately 55% over the next decade, moving away from reliance on older modalities like digital subtraction angiography.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Magnetic Resonance Angiography Market insights. See full methodology.
Market Scope
|
Report Coverage
|
Details
|
Page number
|
288
|
Base year
|
2024
|
Historic period
|
2019 - 2023 |
Forecast period
|
2025-2029
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 5.6%
|
Market growth 2024-2029
|
USD 934.3 million
|
Market structure
|
Fragmented
|
YoY growth 2024-2029(%)
|
5.5%
|
Key countries
|
US, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, The Netherlands, China, India, Japan, South Korea, Indonesia, Thailand, Singapore, Brazil, Australia, South Africa, UAE, Saudi Arabia, Turkey
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Magnetic Resonance Angiography Market Research and Growth Report?
- CAGR of the Magnetic Resonance Angiography industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the magnetic resonance angiography market growth of industry companies
We can help! Our analysts can customize this magnetic resonance angiography market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Technique
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global Magnetic Resonance Angiography Market 2019 - 2023
- Historic Market Size - Data Table on Global Magnetic Resonance Angiography Market 2019 - 2023 ($ billion)
- 5.2 Technique segment analysis 2019 - 2023
- Historic Market Size - Technique Segment 2019 - 2023 ($ billion)
- 5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ billion)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Five Forces Analysis
- 6 Five Forces Analysis
- 6.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 6.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 6.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 6.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 6.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 6.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 6.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
7 Market Segmentation by Technique
- 7 Market Segmentation by Technique
- 7.1 Market segments
- Chart on Technique - Market share 2024-2029 (%)
- Data Table on Technique - Market share 2024-2029 (%)
- 7.2 Comparison by Technique
- Chart on Comparison by Technique
- Data Table on Comparison by Technique
- 7.3 Non-contrast enhanced MRA - Market size and forecast 2024-2029
- Chart on Non-contrast enhanced MRA - Market size and forecast 2024-2029 ($ billion)
- Data Table on Non-contrast enhanced MRA - Market size and forecast 2024-2029 ($ billion)
- Chart on Non-contrast enhanced MRA - Year-over-year growth 2024-2029 (%)
- Data Table on Non-contrast enhanced MRA - Year-over-year growth 2024-2029 (%)
- 7.4 Contrast enhanced MRA - Market size and forecast 2024-2029
- Chart on Contrast enhanced MRA - Market size and forecast 2024-2029 ($ billion)
- Data Table on Contrast enhanced MRA - Market size and forecast 2024-2029 ($ billion)
- Chart on Contrast enhanced MRA - Year-over-year growth 2024-2029 (%)
- Data Table on Contrast enhanced MRA - Year-over-year growth 2024-2029 (%)
- 7.5 Market opportunity by Technique
- Market opportunity by Technique ($ billion)
- Data Table on Market opportunity by Technique ($ billion)
8 Market Segmentation by Application
- 8 Market Segmentation by Application
- 8.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 8.3 Abdomen - Market size and forecast 2024-2029
- Chart on Abdomen - Market size and forecast 2024-2029 ($ billion)
- Data Table on Abdomen - Market size and forecast 2024-2029 ($ billion)
- Chart on Abdomen - Year-over-year growth 2024-2029 (%)
- Data Table on Abdomen - Year-over-year growth 2024-2029 (%)
- 8.4 Lower extremities - Market size and forecast 2024-2029
- Chart on Lower extremities - Market size and forecast 2024-2029 ($ billion)
- Data Table on Lower extremities - Market size and forecast 2024-2029 ($ billion)
- Chart on Lower extremities - Year-over-year growth 2024-2029 (%)
- Data Table on Lower extremities - Year-over-year growth 2024-2029 (%)
- 8.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
9 Market Segmentation by End-user
- 9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ billion)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ billion)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- 9.4 Imaging centers - Market size and forecast 2024-2029
- Chart on Imaging centers - Market size and forecast 2024-2029 ($ billion)
- Data Table on Imaging centers - Market size and forecast 2024-2029 ($ billion)
- Chart on Imaging centers - Year-over-year growth 2024-2029 (%)
- Data Table on Imaging centers - Year-over-year growth 2024-2029 (%)
- 9.5 Ambulatory surgical centers - Market size and forecast 2024-2029
- Chart on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ billion)
- Data Table on Ambulatory surgical centers - Market size and forecast 2024-2029 ($ billion)
- Chart on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
- Data Table on Ambulatory surgical centers - Year-over-year growth 2024-2029 (%)
- 9.6 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)
10 Customer Landscape
- 10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 11.3.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 11.3.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 11.3.3 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 11.4.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 11.4.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 11.4.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 11.4.4 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 11.4.5 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 11.4.6 Russia - Market size and forecast 2024-2029
- Chart on Russia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Russia - Market size and forecast 2024-2029 ($ billion)
- Chart on Russia - Year-over-year growth 2024-2029 (%)
- Data Table on Russia - Year-over-year growth 2024-2029 (%)
- 11.4.7 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- 11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 11.5.1 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 11.5.2 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 11.5.3 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 11.5.4 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 11.5.5 Indonesia - Market size and forecast 2024-2029
- Chart on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- 11.5.6 Thailand - Market size and forecast 2024-2029
- Chart on Thailand - Market size and forecast 2024-2029 ($ billion)
- Data Table on Thailand - Market size and forecast 2024-2029 ($ billion)
- Chart on Thailand - Year-over-year growth 2024-2029 (%)
- Data Table on Thailand - Year-over-year growth 2024-2029 (%)
- 11.5.7 Singapore - Market size and forecast 2024-2029
- Chart on Singapore - Market size and forecast 2024-2029 ($ billion)
- Data Table on Singapore - Market size and forecast 2024-2029 ($ billion)
- Chart on Singapore - Year-over-year growth 2024-2029 (%)
- Data Table on Singapore - Year-over-year growth 2024-2029 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 11.6.1 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 11.6.2 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 11.6.3 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 11.6.4 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 11.6.5 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 11.6.6 Turkey - Market size and forecast 2024-2029
- Chart on Turkey - Market size and forecast 2024-2029 ($ billion)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ billion)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- 11.7 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
12 Drivers, Challenges, and Opportunity
- 12 Drivers, Challenges, and Opportunity
- 12.1 Market drivers
- Increasing prevalence of cardiovascular and neurological diseases
- Technological advancements and innovations in MRA techniques
- Growing preference for non-invasive and radiation-free diagnostic procedures
- 12.2 Market challenges
- High cost of MRA systems and procedures
- Scarcity of skilled radiologists and technicians
- Technical limitations and patient-related issues
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 12.4 Market opportunities
- Integration of artificial intelligence and machine learning
- Rise of non-contrast MRA techniques
- Development of portable and lower-field MRI systems
13 Competitive Landscape
- 13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14 Competitive Analysis
- 14.1 Companies profiled
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Alltech Medical Systems LLC
- Alltech Medical Systems LLC - Overview
- Alltech Medical Systems LLC - Product / Service
- Alltech Medical Systems LLC - Key offerings
- SWOT
- 14.5 ASG Superconductors Spa
- ASG Superconductors Spa - Overview
- ASG Superconductors Spa - Product / Service
- ASG Superconductors Spa - Key offerings
- SWOT
- 14.6 Bruker Corp.
- Bruker Corp. - Overview
- Bruker Corp. - Business segments
- Bruker Corp. - Key news
- Bruker Corp. - Key offerings
- Bruker Corp. - Segment focus
- SWOT
- 14.7 Esaote Spa
- Esaote Spa - Overview
- Esaote Spa - Product / Service
- Esaote Spa - Key offerings
- SWOT
- 14.8 GE Healthcare Technologies Inc.
- GE Healthcare Technologies Inc. - Overview
- GE Healthcare Technologies Inc. - Business segments
- GE Healthcare Technologies Inc. - Key news
- GE Healthcare Technologies Inc. - Key offerings
- GE Healthcare Technologies Inc. - Segment focus
- SWOT
- 14.9 Hitachi Ltd.
- Hitachi Ltd. - Overview
- Hitachi Ltd. - Business segments
- Hitachi Ltd. - Key news
- Hitachi Ltd. - Key offerings
- Hitachi Ltd. - Segment focus
- SWOT
- 14.10 IMRIS Deerfield Imaging Inc.
- IMRIS Deerfield Imaging Inc. - Overview
- IMRIS Deerfield Imaging Inc. - Product / Service
- IMRIS Deerfield Imaging Inc. - Key offerings
- SWOT
- 14.11 Koninklijke Philips NV
- Koninklijke Philips NV - Overview
- Koninklijke Philips NV - Business segments
- Koninklijke Philips NV - Key news
- Koninklijke Philips NV - Key offerings
- Koninklijke Philips NV - Segment focus
- SWOT
- 14.12 Neusoft Medical Systems Co. Ltd.
- Neusoft Medical Systems Co. Ltd. - Overview
- Neusoft Medical Systems Co. Ltd. - Product / Service
- Neusoft Medical Systems Co. Ltd. - Key offerings
- SWOT
- 14.13 Samsung Electronics Co. Ltd.
- Samsung Electronics Co. Ltd. - Overview
- Samsung Electronics Co. Ltd. - Business segments
- Samsung Electronics Co. Ltd. - Key news
- Samsung Electronics Co. Ltd. - Key offerings
- Samsung Electronics Co. Ltd. - Segment focus
- SWOT
- 14.14 Shanghai United Imaging Healthcare Co. Ltd.
- Shanghai United Imaging Healthcare Co. Ltd. - Overview
- Shanghai United Imaging Healthcare Co. Ltd. - Product / Service
- Shanghai United Imaging Healthcare Co. Ltd. - Key offerings
- SWOT
- 14.15 Shenzhen Anke High tech Co.
- Shenzhen Anke High tech Co. - Overview
- Shenzhen Anke High tech Co. - Product / Service
- Shenzhen Anke High tech Co. - Key offerings
- SWOT
- 14.16 Shimadzu Corp.
- Shimadzu Corp. - Overview
- Shimadzu Corp. - Business segments
- Shimadzu Corp. - Key news
- Shimadzu Corp. - Key offerings
- Shimadzu Corp. - Segment focus
- SWOT
- 14.17 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key news
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 14.18 Time Medical Holding
- Time Medical Holding - Overview
- Time Medical Holding - Product / Service
- Time Medical Holding - Key offerings
- SWOT
15 Appendix
- 15 Appendix
- 15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.5 Data procurement
- 15.6 Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations